SenesTech - SNES Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for SenesTech in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" SNES shares.
View SNES analyst ratings or view top-rated stocks.

SenesTech's stock was trading at $0.9788 at the start of the year. Since then, SNES stock has decreased by 30.5% and is now trading at $0.68.
View the best growth stocks for 2022 here.

SenesTech saw a drop in short interest in July. As of July 15th, there was short interest totaling 23,600 shares, a drop of 49.5% from the June 30th total of 46,700 shares. Based on an average trading volume of 32,800 shares, the days-to-cover ratio is presently 0.7 days. Approximately 0.2% of the shares of the stock are short sold.
View SenesTech's Short Interest.

SenesTech is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022.
View our SNES earnings forecast.

SenesTech will be holding an earnings conference call on Thursday, August 11th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "4931404".

SenesTech, Inc. (NASDAQ:SNES) released its quarterly earnings results on Thursday, May, 12th. The company reported ($0.19) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.21) by $0.02. The firm earned $0.20 million during the quarter, compared to analyst estimates of $0.19 million. SenesTech had a negative net margin of 1,241.73% and a negative trailing twelve-month return on equity of 78.77%.

Shares of SenesTech reverse split on the morning of Wednesday, February 5th 2020. The 1-20 reverse split was announced on Tuesday, February 4th 2020. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 4th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other SenesTech investors own include TransEnterix (TRXC), Carrizo Oil & Gas (CRZO), Auris Medical (EARS), Marathon Oil (MRO), Adamis Pharmaceuticals (ADMP), McDermott International (MDR), ZIOPHARM Oncology (ZIOP), Citius Pharmaceuticals (CTXR) and DURECT (DRRX).

(SNES) raised $15 million in an IPO on Thursday, December 8th 2016. The company issued 1,900,000 shares at $8.00 per share. Roth Capital Partners acted as the underwriter for the IPO and Craig-Hallum Capital Group was co-manager.

SenesTech trades on the NASDAQ under the ticker symbol "SNES."

Shares of SNES stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SNES stock can currently be purchased for approximately $0.68.

SenesTech (NASDAQ:SNES) has a market capitalization of $8.30 million and generates $600,000.00 in revenue each year. The company earns $-8,270,000.00 in net income (profit) each year or ($0.68) on an earnings per share basis.

SenesTech employs 26 workers across the globe.

SenesTech's mailing address is 23460 NORTH 19TH AVENUE SUITE 110, PHOENIX AZ, 85027. The official website for the company is www.senestech.com. The company can be reached via phone at (928) 779-4143 or via email at senestech@lythampartners.com.